Brief: Intervacc Applies For Permit For Sale Of Strangvac In US

Intervacc AB

16/02/2022 07:34

Feb 16 (Reuters) - Intervacc AB  IVACC.ST :
    * INTERVACC APPLIES FOR A PERMIT FOR SALE AND DISTRIBUTION
OF
STRANGVAC IN THE U.S.
    * COMPANY'S APPLICATION FOR A PERMIT FOR SALE AND
DISTRIBUTION OF
STRANGVAC IN U.S. HAS BEEN SUBMITTED TO U.S. DEPARTMENT OF
AGRICULTURE (USDA).
    * IS SEEKING APPROVAL FOR STRANGVAC, A VACCINE AGAINST
HIGHLY
CONTAGIOUS EQUINE DISEASE STRANGLES THAT AFFECTS HORSES
WORLDWIDE
    * STRANGVAC HAS BEEN APPROVED FOR USE IN EUROPEAN UNION,
UNITED
KINGDOM, NORWAY, AND ICELAND SINCE AUTUMN OF 2021.

Source text for Eikon:  ID:nWkr8l6JV9 
Further company coverage:  IVACC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))